Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Harvard Business School
Medtronic
Johnson and Johnson
Moodys

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Patent: 9,511,055

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 9,511,055
Title:Angiotensin in treating brain conditions
Abstract: The present invention provides, among other things, methods and compositions for treating brain conditions. In some embodiments, the methods include administering to a subject suffering from or susceptible to a brain condition an angiotensin (1-7) peptide via either an intravenous or subcutaneous route of administration.
Inventor(s): Franklin; Richard (Cambridge, MA)
Assignee: Tarix Pharmaceuticals Ltd. (Cambridge, MA)
Application Number:13/897,051
Patent Claims:see list of patent claims

Details for Patent 9,511,055

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Novartis Pharms EXTAVIA interferon beta-1b INJECTABLE; SUBCUTANEOUS 125290 001 2009-08-14   Start Trial Tarix Pharmaceuticals Ltd. (Cambridge, MA) 2032-10-02 RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23   Start Trial Tarix Pharmaceuticals Ltd. (Cambridge, MA) 2032-10-02 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07   Start Trial Tarix Pharmaceuticals Ltd. (Cambridge, MA) 2032-10-02 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07   Start Trial Tarix Pharmaceuticals Ltd. (Cambridge, MA) 2032-10-02 RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17   Start Trial Tarix Pharmaceuticals Ltd. (Cambridge, MA) 2032-10-02 RX search
Bayer Healthcare Pharms BETASERON interferon beta-1b VIAL; SUBCUTANEOUS 103471 001 1993-07-23   Start Trial Tarix Pharmaceuticals Ltd. (Cambridge, MA) 2032-10-02 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Colorcon
Johnson and Johnson
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.